Suchergebnisse - "Li, Zexu"

PubPharm (39)

1

USP10 strikes down β-catenin by dual-wielding deubiquitinase activity and phase separation potential

enthalten in: bioRxiv.org | 2024

von Wang, Y. | Mao, A. | Liu, J. | +21

2

A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism

enthalten in: bioRxiv.org | 2024

von Yao, Y. | Zhang, Y. | Li, Z. | +11

3

USE OF PLK4-TARGETING DRUG IN TREATMENT OF PLATINUM DRUG-RESISTANT TUMORS

enthalten in: Europäisches Patentamt | 2024

von FEI TENG | ZHONG CHUNGE | LI ZEXU

4

USE OF PLK4-TARGETING DRUG IN TREATMENT OF PLATINUM DRUG-RESISTANT TUMORS

enthalten in: Europäisches Patentamt | 2024

von FEI TENG | ZHONG CHUNGE | LI ZEXU

5

Intrinsic targeting of host RNA by Cas13 constrains its utility

enthalten in: Nature biomedical engineering | 2024

von Li, Z. | Li, Z. | Cheng, X. | +12

6

Digital neuropsychological measures by defense automated neurocognitive assessment : reference values and clinical correlates

enthalten in: Frontiers in neurology | 2024

von Ding, H. | Kim, M. | Searls, E. | +14

7

USP10 strikes down β-catenin by dual-wielding deubiquitinase activity and phase separation potential

enthalten in: Cell chemical biology | 2023

von Wang, Y. | Mao, A. | Liu, J. | +21

8

Application of PLK4 targeted drug in treatment of platinum drug-resistant tumors

enthalten in: Europäisches Patentamt | 2023

von FEI TENG | ZHONG CHUNGE | LI ZEXU

9

Application of PLK4 targeted drug in treatment of platinum drug-resistant tumors

enthalten in: Europäisches Patentamt | 2023

von FEI TENG | ZHONG CHUNGE | LI ZEXU

10

A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism

enthalten in: Biochemical and biophysical research communications | 2023

von Yao, Y. | Zhang, Y. | Li, Z. | +11